MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

GELS — Gelteq Limited Ordinary Shares

Nasdaq

Gelteq Limited Ordinary Shares

CompareBack to Screener
$0.52
-0.02(-3.96%)
O
0.53
H
0.54
L
0.52
V
70.17K
⏱️ End-of-day dataAs of Oct 2, 2026

Chart

About GELS

Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.

IndustryCommon Stock
SectorNot available
IPO DateOct 29, 2024
Employees8
Stock ExchangeNasdaq
Ticker SymbolGELS

Key Financial Statistics

Market Cap$5.58M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$0.39 - $2.01
52-Week Avg Volume2.09M
VWAP$0.53
Transactions184
Total Recorded Bars483 days